Cytoplasmic domain of proEGF affects distribution and post-translational modification of microtubuli and increases microtubule-associated proteins 1b and 2 production in human thyroid carcinoma cells

Cancer Research

Volumn 65, Issue 4, 2005, Pages 1343-1351

  Pyka, Janette ^a   Glogowska, Aleksandra ^b   Dralle, Henning ^a   Hoang Vu, Cuong ^a   Klonisch, Thomas ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ISOPROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 5; PROTEIN PRECURSOR;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; EXON; FOLLICULAR CARCINOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROTUBULE; PAPILLARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; THYROID CARCINOMA; TRANSCRIPTION REGULATION; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, PAPILLARY; CHILD; CYTOPLASM; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PROTEIN ISOFORMS; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; THYROID NEOPLASMS; TRANSFECTION; TUBULIN;

EID: 13944257722     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2030     Document Type: Article

References (56)

1. Massague J, Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem 1993;62:515-41.
2. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003;284:31-53.
3. Marti U, Ruchti C, Kampf J, Thomas GA, Williams ED, Peter HJ, Gerber H, Burgi U. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid 2001;11:137-45.
4. Hoelting T, Siperstein AE, Clark OH, Duh QY. Epidermal growth factor (EGF)- and transforming growth factor α stimulated invasion and growth of follicular thyroid cancer cells can be bloched by antagonism to the EGF receptor and tyrosine kinase in vitro. Eur J Endocrinol 1995;132:229-35.
5. Gorgoulis V, Aninos D, Priftis C, et al. Expression of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in thyroid tumors. In Vivo 1992;6:291-6.
6. Aasland R, Akslen LA, Varhaug JE, Lillehaug JR. Co-expression of the genes encoding transforming growth factor-α and its receptor in papillary carcinomas of the thyroid. Int J Cancer 1990;46:382-7.
7. Sahin U, Weskamp G, Kelly K, et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004;164:769-79.
8. Rall LB, Scott J, Bell GI, et al. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 1985;313:228-31.
9. Dobashi Y, Stern DF. Membrane-anchored forms of EGF stimulate focus formation and intercellular communication. Oncogene 1991;6:1151-9.
10. Takemura T, Kondo S, Homma T, Sakai M, Harris RC. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J Biol Chem 1997;272:31036-42.
11. Brown CL, Coffey RJ, Dempsey PJ. The proamphiregulin cytoplasmic domain is required for basolateral sorting, but is not essential for constitutive or stimulus-induced processing in polarized Madin-Darby canine kidney cells. J Biol Chem 2001;276:36862.
12. Dong J, Wiley HS. Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains. J Biol Chem 2000;275:557-64.
13. Dempsey PJ, Meise KS, Coffey RJ. Basolateral sorting of transforming growth factor-α precursor in polarized epithelial cells: characterization of cytoplasmic domain determinants. Exp Cell Res 2003;285:159-74.
14. Bosenberg MW, Pandiella A, Massague J. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF α into soluble growth factor. Cell 1992;71:1157-65.
15. Shum L, Reeves SA, Kuo AC, Fromer ES, Derynck R. Association of the transmembrane TGF-α precursor with a protein kinase complex. J Cell Biol 1994;125:903-16.
16. Nanba D, Mammoto A, Hashimoto K, Higashiyama S. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol 2003;163:489-502.
17. Nanba D, Higashiyama S. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor. Cytokine Growth Factor Rev 2004;15:13-9.
18. Bao J, Wolpowitz D, Role LW, Talmage DA. Back signaling by the Nrg-1 intracellular domain. J Cell Biol 2003;161:1133-4.
19. Sambrook J, Russel DW. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 2001.
20. Bell GI, Fong NM, Stempien MM, et al. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 1986;14:8427-46.
21. Toda S, Nishimura T, Yamada S, et al. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture. J Pathol 1999;188:415-22.
22. Mizukami Y, Nonomura A, Hashimoto T, et al. Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues. Histopathology 1991;18:11-8.
23. Paschke R, Eck T, Herfurth J, Usadel KH. Stimulation of proliferation and inhibition of function of xenotransplanted human thyroid tissue by epidermal growth factor. J Endocrinol Invest 1995;18:359-63.
24. Miyamoto M, Sugawa H, Kuma K, Mori T, Imura H. Analysis of epidermal growth factor (EGF) receptor and effect of EGF on the growth of cultured Graves' and non-neoplastic human thyroid cells. J Endocrinol Invest 1989;12:111-7.
25. Errick JE, Ing KW, Eggo MC, Burrow GN. Growth and differentiation in cultured human thyroid cells: effects of epidermal growth factor and thyrotropin. In Vitro Cell Dev Biol Anim 1986;22:28-36.
26. Roger PP, Van Heuverswyn B, Lambert C, Reuse S, Vassart G, Dumont JE. Antagonistic effects of thyrotropin and epidermal growth factor on thyroglobulin mRNA level in cultured thyroid cells. Eur J Biochem 1985;152:239-45.
27. Westermark K, Westermark B. Mitogenic effect of epidermal growth factor on sheep thyroid cells in culture. Exp Cell Res 1982;138:47-55.
28. Lemoine NR, Hughes CM, Gullick WJ, Brown CL, Wynford-Thomas D. Abnormalities of the EGF receptor system in human thyroid neoplasia. Int J Cancer 1991;49:558-61.
29. van der Laan BF, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995;5:67-73.
30. Nakano N, Higashiyama S, Kajihara K, et al. NTAKα and β isoforms stimulate breast tumor cell growth by means of different receptor combinations. J Biochem (Tokyo) 2000;127:925-30.
31. Urena JM, Merlos-Suarez A, Baselga J, Arribas J. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(α) and membrane type matrix metalloprotease (MT1-MMP). J Cell Sci 1999;112:773-84.
32. Abal M, Andreu JM, Barasoain I. Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. Curr Cancer Drug Targets 2003;3:193-203.
33. Chen JG, Horwitz SB. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 2002;62:1935-8.
34. Kavallaris M, Tait AS, Walsh BJ, et al. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res 2001;61:5803-9.
35. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 1980;77:1561-5.
36. Palazzo A, Ackerman B, Gundersen GG. Cell biology: tubulin acetylation and cell motility. Nature 2003;421:230.
37. Elliot G, O'Hare P. Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J Virol 1998;72:6448-55.
38. Ilschner S, Brandt R. The transition of microglia to a ramified phenotype is associated with the formation of stable acetylated and detyrosinated microtubules. Glia 1996;18:129-40.
39. Piperno G, LeDizet M, Chang XJ. Microtubules containing acetylated α-tubulin in mammalian cells in culture. J Cell Biol 1987;104:289-302.
40. LeDizet M, Piperno G. Cytoplasmic microtubules containing acetylated α-tubulin in Chlamydomonas reinhardtii: spatial arrangement and properties. J Cell Biol 1986;103:13-22.
41. Hubbert C, Guardiola A, Shao R, et al. HDAC6 is a microtubule-associated deacetylase. Nature 2002;417:455-8.
42. Honore S, Kamath K, Braguer D, Wilson L, Briand C, Jordan MA. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Mol Cancer Ther 2003;2:1303-11.
43. Verrills NM, Walsh BJ, Cobon GS, Hains PG, Kavallaris M. Proteome analysis of Vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J Biol Chem 2003;278:45082-93.
44. Jordan MA, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991;51:2212-22.
45. Goncalves A, Braguer D, Kamath K, et al. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc Natl Acad Sci U S A 2001;98:11737-42.
46. Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998;10:123-30.
47. Bouquet C, Soares S, von Boxberg Y, et al. Microtubule-associated protein 1B controls directionality of growth cone migration and axonal branching in regeneration of adult dorsal root ganglia neurons. J Neurosci 2004;24:7204-13.
48. Gonzalez-Billaut C, Avila J, Caceres A. Evidence for the role of MAP1B in axon formation. Mol Biol Cell 2001;12:2087-98.
49. Griffith LM, Pollard TD. The interaction of actin filaments with microtubules and microtubule-associated proteins. J Biol Chem 1982;257:9143-51.
50. Pedrotti B, Francolini M, Cotelli F, Islam K. Modulation of microtubule shape in vitro by high molecular weight microtubule associated proteins MAF1A, MAP1B, and MAP2. FEBS Lett 1996;384:147-50.
51. Gamblin TC, Nachmanoff K, Halpain S, Williams RC. Recombinant microtubule-associated protein 2c reduces the dynamic instability of individual microtubules. Biochemistry 1996;35:12576-86.
52. Feralli J, Doll T, Matus A. Sequence analysis of MAP2 function in living cells. J Cell Sci 1994;107:3115-25.
53. Hirokawa N. Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol 1994;6:74-81.
54. Boucher D, Larcher JC, Gros F, Denoulet P. Polyglutamylation of tubulin as a progressive regulator of in vitro interactions between the microtubule-associated protein Tau and tubulin. Biochemistry 1994;33:12471-7.
55. Bonnet C, Boucher D, Lazereg S, et al. Differential binding regulation of microtubule-associated proteins MAP1A, MAP1B, and MAP2 by tubulin polyglutamylation. J Biol Chem 2001;276:12839-48.
56. Bobinnec Y, Khodjakov A, Mir LM, Rieder CL, Edde B, Bornens M. Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells. J Cell Biol 1998;143:1575-89.